Alteration in specific opioid-receptor labeling on peripheral blood leukocytes of bile duct-ligated rat

Pathophysiology

Volumn 13, Issue 2, 2006, Pages 111-117

  Mombeini, Tajemah ^a,b   Roushanzamir, Farshad ^a   Jorjani, Masoumeh ^a   Pourpak, Zahra ^a   Gaskari, Seyed Ali ^a   Mehr, Shahram Ejtemaie ^a   Dehpour, Ahmad Reza ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b SHAHED UNIVERSITY   (Iran)

Author keywords

Cholestasis; Direct immunofluorescence; Opioid receptor; Peripheral blood leukocytes; Rat

Indexed keywords

FLUORESCEIN; NALTREXONE; OPIATE RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BILE DUCT LIGATION; CELL ISOLATION; CELL LABELING; CHEMICAL LABELING; CHOLESTASIS; CONTROLLED STUDY; FLOW CYTOMETRY; GRANULOCYTE; LEUKOCYTE; LEUKOCYTE COUNT; MALE; MONOCYTE; NONHUMAN; PATHOPHYSIOLOGY; PERIPHERAL CIRCULATION; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROTEIN CONTENT; PROTEIN EXPRESSION; PROTEIN INTERACTION; QUANTITATIVE ANALYSIS; RAT; REGULATORY MECHANISM;

EID: 33646113591     PISSN: 09284680     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pathophys.2006.02.002     Document Type: Article

References (40)

1. Clement-Jones V., Lowry P.J., Rees L.H., and Besser G.M. Metenkephaline circulates in human plasma. Nature 283 (1980) 295-297
2. Swain M.G., Rothman R.B., Xu H., Vergalla J., Bergasa N.V., and Jones E.A. Endogenous opioids accumulate in plasma in a rat model of acute cholestasis. Gastroenterology 103 (1992) 630-635
3. Thornton J.R., and Losowsky M.S. Opioid peptides and primary biliary cirrhosis. Br. Med. J. 297 (1988) 1501-1504
4. Thornton J.R., and Losowsky M.S. Plasma methionine enkephalin concentrations and prognosis in primary biliary cirrhosis. Br. Med. J. 297 (1988) 1241-1242
5. Bergasa N.V., Alling D.W., Vergalla J., and Jones E.A. Cholestasis in the male rat is associated with naloxone-reversible antinociception. J. Hepatol. 20 (1994) 85-90
6. Ghafourifar P., Dehpour A.R., and Akbarloo N. Inhibition by L-NA, a nitric oxide synthase inhibitor, of naloxone-precipitated withdrawal signs in a mouse model of cholestasis. Life Sci. 60 (1997) 265-270
7. Jones E.A., and Bergasa N.V. The pruritus of cholestasis: from bile acid to opiate agonists. Hepatology 11 (1990) 884-887
8. Dehpour A.R., Akbarloo N., and Ghafourifar P. Endogenous nitric oxide modulates naloxone-precipitated withdrawal signs in a mouse model with acute cholestasis. Behav. Pharmacol. 9 (1998) 77-80
9. Bergasa N.V., Rothman R.B., Vergalla J., Xu H., Swain M.G., and Jones E.A. Central mu-opioid receptors are down-regulated in a rat model of cholestasis. J. Hepatol. 15 (1992) 220-224
10. Sibinga N.E.S., and Goldstein A. Opioid peptides and opioid receptors in cells of the immune system. Ann. Rev. Immunol. 6 (1988) 219-249
11. Sharp B.M., Keane W.F., Suh H.I., Gekker G., Tsukayama D., and Peterson P.K. Opioid peptides rapidly stimulate superoxide production by human polymorphonuclear leukocytes and macrophages. Endocrinology 117 (1985) 793-795
12. Perez-Castrillon J.L., Perez-Arellano J.L., Garcia-Palomo J.D., Jimenez-Lopez A., and De Castro S. Opioid depresses in vitro human monocyte chemotaxis. Immunopharmacology 23 (1992) 57-61
13. Swain M.G., Tijandra K., Kanwar S., and Kubes P. Neutrophil adhesion is impaired in rat model of cholestasis. Gastroenterology 109 (1995) 923-932
14. Tijandra K., Woodman R.C., and Swain M.G. Impaired neutrophil microbicidal activity in rat cholestasis. Gastroenterology 112 (1997) 1692-1698
15. Jones D.E., Palmer J.M., Leon M.P., Yeaman S.J., Bassendine M.F., and Diamond A.G. T cell responses to tuberculin purified protein derivative in primary biliary cirrhosis: evidence for defective T cell function. Gut 40 (1997) 277-283
16. Sharp B.M. Opioid receptor expression and intracellular signaling by cells involved in host defense and immunity. Adv. Exp. Med. Biol. 521 (2003) 98-105
17. Bidlack J.M. Detection and function of opioid receptors on cells from the immune system. Clin. Diag. Lab. Immunol. 7 (2000) 719-723
18. Kolb V.M., Koman A., and Terenius L. Fluorescent probes for opioid receptor. Life Sci. 33 (1983) 423-426
19. Koman A., Einarsson M., and Terenius L. Agonist-antagonist properties of fluorescent opioid probes in the guinea-pig myenteric plexus-longitudinal muscle preparation. Naunyn Schmiedebergs Arch. Pharmacol. 331 (1985) 355-358
20. Lang M.E., Davison J.S., Bates S.L., and Meddings J.B. Opioid receptors on guinea-pig intestinal crypt epithelial cells. J. Physiol. 497 (1996) 161-174
21. Lawrence D.M.P., Hutchinson I., Seyed-Mozaffari A., Archer S., and Bidlack J.M. Fluorescent staining of κ opioid receptors using naltrexamine derivatives and phycoerythrin. J. Immunol. Meth. 201 (1997) 173-181
22. Lang M.E., Jourd'heuil D., Meddings J.B., and Swain M.G. Increased opioid binding to peripheral white blood cells in a rat model of acute cholestasis. Gastroenterology 108 (1995) 1479-1486
23. Cameron G.R., and Oakley C.L. Ligation of the common bile duct. J. Pathol. Bacteriol. 35 (1932) 769-798
24. Boyum A. Isolation of leucocytes from human blood. J. Clin. Lab. Invest. 21 (1968) 39-50
25. Ignatowski T.A., and Bidlack J.M. Detection of kappa opioid receptors on mouse thymocyte phenotypic subpopulations as assessed by flow cytometry. J. Pharmacol. Exp. Ther. 284 (1998) 298-306
26. Rose N.R., Hamilton R.G., and Detrick B. Manual of Clinical Laboratory Immunology (2002), ASM Press, Washington pp. 141-143
27. Dehpour A.R., Rastegar H., Jorjani M., Roushanzamir F., Joharchi K., and Ahmadiani A. Subsensitivity to opioids is receptor specific in isolated guinea pig ileum and mouse vas deferens after obstructive cholestasis. J. Pharmacol. Exp. Ther. 293 (2000) 1-6
28. Fecho K., Maslonek K.A., Dykstra L.A., and Lysle D.T. Assessment of the involvement of central nervous system and peripheral opioid receptors in the immunomodulatory effects of acute morphine treatment in rats. J. Pharmacol. Exp. Ther. 276 (1996) 626-636
29. Mellon R.D., and Bayer B.M. Role of central opioid receptor subtypes in morphine-induced alterations in peripheral lymphocyte activity. Brain Res. 798 (1998) 56-67
30. Schneider G.M., and Lysle D.T. Role of central mu-opioid receptors in the modulation of nitric oxide production by splenocytes. J. Neuroimmunol. 89 (1998) 150-159
31. Patrini G., Massi P., Ricevuti G., Mazzone A., Fossati G., Mazzucchelli I., Gori E., and Parolaro D. Changes in opioid receptor density on murine splenocytes induced by in vivo treatment with morphine and methadone. J. Pharmacol. Exp. Ther. 279 (1996) 172-176
32. Martin-Kleiner I., and Bidlack J.M. Chronic opioid treatment of the mouse thymoma cell lines R1.G1 and R1EGO leads to down-regulation of kappa opioid receptor without desensitization of adenylyl cyclase activity. Int. Immunopharmacol. 1 (2001) 13-20
33. Mazzone A., Mazzucchelli I., Fossati G., Gritti D., Fea M., and Ricevuti G. Granulocyte defects and opioid receptors in chronic exposure to heroin or methadone in humans. Int. J. Immunopharmacol. 16 (1994) 959-967
34. Suzuki S., Miyagi T., Chuang T.K., Chuang L.F., Doi R.H., and Chuang R.Y. Morphine upregulates mu opioid receptors of human and monkey lymphocytes. Biochem. Biophys. Res. Commun. 279 (2000) 621-628
35. Suzuki S., Chuang T.K., Chuang L.F., Doi R.H., and Chuang R.Y. Morphine upregulates kappa-opioid receptors of human lymphocytes. Adv. Exp. Med. Biol. 493 (2001) 81-87
36. Suzuki S., Chaung L.F., Doi R.H., Bidlack J.M., and Chaung R.Y. Kappa-opioid receptors on lymphocytes of a human lymphocytic cell line: morphine-induced up-regulation as evidenced by competitive RT-PCR and direct immunofluorescence. Int. Immunopharmacol. 1 (2001) 1733-1742
37. Dehpour A.R., Mani A.R., Amanlou M., Nahavandi A., Amanpour S., and Bahadori M. Naloxone is protective against indomethacine-induced gastric damage in cholestatic rats. J. Gastroenterol. 34 (1999) 178-181
38. Nahavandi A., Mani A.R., Homayounfar H., Akbari M.R., and Dehpour A.R. The role of interaction between endogenous opioids and nitric oxide in the pathophysiology of ethanol-induced gastric damage in cholestatic rats. Fundam. Clin. Pharmacol. 15 (2001) 181-187
39. Namiranian K., Samini M., Mehr S.E., Gaskari S.A., Rastegar H., Homayoun H., and Dehpour A.R. Mesenteric vascular bed responsiveness in bile duct-ligated rats: roles of opioid and nitric oxide systems. Eur. J. Pharmacol. 423 (2001) 185-193
40. Gaskari S.A., Mani A.R., Mehr S.E., Namiranian K., Homayoun H., Ahmadi H., and Dehpour A.R. Do endogenous opioids contribute to the bradycardia of rats with obstructive cholestasis?. Fundam. Clin. Pharmacol. 16 (2002) 1-7